Cargando…
Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility
PROBLEM: Many countries have limited experience of securing the best prices for drugs and have little negotiating power. This is particularly true for the complex, lengthy and expensive regimens used to treat multidrug-resistant tuberculosis. APPROACH: The Stop TB Partnership’s Global Drug Facility...
Autores principales: | Lunte, Kaspars, Cordier-Lassalle, Thierry, Keravec, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431560/ https://www.ncbi.nlm.nih.gov/pubmed/26229192 http://dx.doi.org/10.2471/BLT.14.145920 |
Ejemplares similares
-
The Global Drug Facility as an intervention in the market for tuberculosis drugs
por: Arinaminpathy, Nimalan, et al.
Publicado: (2015) -
Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis
por: Tupasi, Thelma, et al.
Publicado: (2016) -
Price reductions in hearing aids and access to audiologists, Israel
por: Lavie, Limor, et al.
Publicado: (2022) -
Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges
por: Aliyu, Gambo, et al.
Publicado: (2017) -
Improving water, sanitation and hygiene in health-care facilities, Liberia
por: Abrampah, Nana Mensah, et al.
Publicado: (2017)